MA49448A - Compositions pharmaceutiques contenant du fumarate de diméthyle - Google Patents

Compositions pharmaceutiques contenant du fumarate de diméthyle

Info

Publication number
MA49448A
MA49448A MA049448A MA49448A MA49448A MA 49448 A MA49448 A MA 49448A MA 049448 A MA049448 A MA 049448A MA 49448 A MA49448 A MA 49448A MA 49448 A MA49448 A MA 49448A
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
compositions containing
dimethyl fumarate
containing dimethyl
fumarate
Prior art date
Application number
MA049448A
Other languages
English (en)
Inventor
Mir Jorge Aubets
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1710114.8A external-priority patent/GB201710114D0/en
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of MA49448A publication Critical patent/MA49448A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA049448A 2017-06-23 2018-06-25 Compositions pharmaceutiques contenant du fumarate de diméthyle MA49448A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1710114.8A GB201710114D0 (en) 2017-06-23 2017-06-23 Pharmaceutical compositions
EP17382402 2017-06-27

Publications (1)

Publication Number Publication Date
MA49448A true MA49448A (fr) 2020-04-29

Family

ID=62791731

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049448A MA49448A (fr) 2017-06-23 2018-06-25 Compositions pharmaceutiques contenant du fumarate de diméthyle

Country Status (9)

Country Link
US (1) US11602515B2 (fr)
EP (1) EP3641736A1 (fr)
JP (1) JP7308763B2 (fr)
KR (1) KR20200018458A (fr)
CN (1) CN110636838A (fr)
AU (1) AU2018287442A1 (fr)
CA (1) CA3059293A1 (fr)
MA (1) MA49448A (fr)
WO (1) WO2018234584A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
DE14172398T1 (de) * 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
MX2007013467A (es) 2005-04-28 2008-01-21 Wyeth Corp Tanaproget micronizado y composiciones que contienen el mismo.
WO2007042034A1 (fr) 2005-10-07 2007-04-19 Aditech Pharma Ab Compositions pharmaceutiques a liberation controlee comportant un ester de l'acide fumarique
WO2007042035A2 (fr) 2005-10-07 2007-04-19 Aditech Pharma Ab Therapie de combinaison pour le traitement d'un trouble auto-immun et/ou inflammatoire et de conditions associees
WO2009118764A1 (fr) 2008-03-28 2009-10-01 Panacea Biotec Limited Composition pharmaceutique comprenant du diclofénac et du paracétamol
WO2010079221A1 (fr) 2009-01-09 2010-07-15 Forward Pharma A/S Composition pharmaceutique comprenant un ou plusieurs esters d'acide fumarique
PT2564839T (pt) 2009-01-09 2016-07-14 Forward Pharma As Formulação farmacêutica compreendendo um ou mais ésteres de ácido fumárico numa matriz de erosão
EP3466420A1 (fr) 2009-04-29 2019-04-10 Biogen MA Inc. Fumarate de diméthyle pour le traitement de l'ataxie de friedreich
JP2014515390A (ja) 2011-06-03 2014-06-30 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Ｐｉ３ｋ阻害剤化合物を用いた中皮腫の治療法
CN114146079A (zh) 2012-02-07 2022-03-08 比奥根玛公司 含有富马酸二甲酯的药物组合物
PT3079666T (pt) 2013-12-12 2021-02-18 Almirall Sa Composições farmacêuticas que contêm fumarato de dimetilo
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle

Also Published As

Publication number Publication date
KR20200018458A (ko) 2020-02-19
CN110636838A (zh) 2019-12-31
JP2020524685A (ja) 2020-08-20
US11602515B2 (en) 2023-03-14
WO2018234584A1 (fr) 2018-12-27
EP3641736A1 (fr) 2020-04-29
US20200197348A1 (en) 2020-06-25
AU2018287442A1 (en) 2019-11-07
JP7308763B2 (ja) 2023-07-14
CA3059293A1 (fr) 2018-12-27

Similar Documents

Publication Publication Date Title
MA46481A (fr) Compositions d'oligonucléotides et méthodes associées
DK3529248T3 (da) Farmaceutiske sammensætninger
MA54411A (fr) Compositions contenant de l'ibrutinib
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
MA50541A (fr) Formulations pharmaceutiques
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
DK3634377T3 (da) Farmaceutisk formulering
HUE053354T2 (hu) Szulfonamid-származékok és ezeket tartalmazó gyógyászati készítmények
DK3532029T3 (da) Flydende farmaceutisk sammensætning
MA42303A (fr) Formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
DK3709978T3 (da) Farmaceutisk oral formulering omfattende bakterier
MA49837A (fr) Compositions pharmaceutiques
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
MA47516A (fr) Composition pharmaceutique
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
IL304109A (en) Pharmaceutical preparations containing spinamide
DK3601277T3 (da) Farmaceutisk formulering
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
MA51009A (fr) Composition de soins buccaux
FR3069158B1 (fr) Agent de nettoyage des cheveux
MA43126A (fr) Compositions pharmaceutiques de fumarate de diméthyle
FR3025096B1 (fr) Composition gel/gel contenant un actif anti-transpirant
MA42552A (fr) Compositions pharmaceutiques de flurbiprofène et de tramadol
MA49625A (fr) Compositions pharmaceutiques